Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease

Edo Savelkoul(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), Arno R. Bourgonje(University Medical Center Groningen), M. Maas(University Medical Center Groningen), Vince Biemans(Radboud University Nijmegen), Gerard Dijkstra(University Medical Center Groningen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Nathan den Broeder(Radboud University Nijmegen), Nanne K.H. de Boer, M.G.V.M. Russel(Medisch Spectrum Twente), Femke Crouwel(Amsterdam University Medical Centers)
Journal of Crohn s and Colitis
March 16, 2022
10.1093/ecco-jcc/jjac044
Cited by 6

Related Papers

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
|Gut|2016|800
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Complex host genetics influence the microbiome in inflammatory bowel disease
|Genome Medicine|2014|431
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
|The Lancet|2022|301
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269